Our Research
MedBliss Research Network investigates biological pathways that contribute to anxiety, depression, and panic disorders. We integrate validated clinical measures with modern microbiome science and advanced analytics to generate rigorous, actionable evidence.
Objectives
- Characterize microbiome features associated with symptom severity.
- Compare profiles between symptomatic cohorts and healthy controls.
- Relate lifestyle, diet, and medication covariates to outcomes.
Design & Measures
Adult participants (18–65). Measures include GAD‑7, PHQ‑9, and PDSS; lifestyle & medication history; one‑time stool sample for sequencing and bioinformatics analysis.
Data Governance
De‑identified data, encryption, role‑based access control, and aggregate reporting.